Fusion Antibodies develop new technologies with support of InvestNI
Invest NI has offered the company R&D support of £22,704 with an additional £46,600 offered to support a broad range of market development activities.
Fusion Antibodies Ltd is helping to turn leading-edge research into novel drugs for the treatment of cancer and other chronic conditions with support from Invest Northern Ireland. With investment support form InvestNI, Fusion Antibodies have developed new technologies to support researchers develop drugs for the clinic. More details can be found on our most recent press release: